[CLSTR]
< Back to situations

[ORGANIZATION]

Gilead Sciences

Featured in 5 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [US] [AU]

US biotech Q2 earnings reports

2 clusters · 12 sources · last updated

Latest: Amgen posts 9% Q2 sales growth and earnings beat as biotech peers report results

In late July 2026 Biogen posted a modest 3% year‑over‑year revenue rise to $2.7 billion, driven by its multiple‑sclerosis drugs and newer products such as Skyclarys and Leqembi. A week later Amgen reported stronger Q2 pe

[ACTIVE] [HEALTH] [POLITICS] [BR] [US] [DE]

AIDS 2026: funding cuts, Brazil surge, community push

8 clusters · 151 sources · last updated

Latest: Rio AIDS 2026 conference shows vibrant community expression and US funding controversy

The 26th International AIDS Conference (July 26‑31, 2026) convened over 20,000 scientists, clinicians, activists and people living with HIV in Rio de Janeiro. The AIDS Healthcare Foundation used its exhibition space to

[QUIET] [HEALTH] [BR] [GB] [IN]

Global HIV‑prevention outreach and PrEP uptake challenges

2 clusters · 8 sources · last updated

Latest: Gilead’s US HIV prevention campaign and South African study reveal challenges in PrEP uptake

At the International AIDS Conference 2026 in Rio de Janeiro, Grindr for Equality announced a pledge to connect ten million LGBTQ+ users to HIV‑prevention services by 2028. The commitment follows the "Closing the Gap" rep

Also covered in